Condition
Primary Immunodeficiency Diseases (PID) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Primary Immunodeficiency Diseases (PID) clinical trials that are recruiting, at sites in 2 countries (most in Japan (1), Belgium (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ex vivo testing of JAK inhibitors and a gene-therapy approach for JAK-STAT related immune disorders
This project will try JAK-inhibitor drugs and a gene-therapy approach on blood samples from adults with JAK-STAT pathway primary immunodeficiencies and healthy controls to see how immune cells and gene expression change.
-
Evaluating the safety of a 20% Immune Globulin solution in patients with primary immunodeficiency
This study is trying to see if a 20% immune globulin solution is safe for people with primary immunodeficiency diseases by looking at past patient data from Japan.
Quick answers
How many Primary Immunodeficiency Diseases (PID) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Japan (1 trial), Belgium (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.